Pharmacy News

FDA denies emergency use nod for Covaxin in US, Health News, ET HealthWorld

New Delhi: The US Food and Drug administration has denied approval for emergency use of Bharat Biotech’s Covaxin, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.

FDA recommended that Ocugen “pursue a Biologics Licence Application (BLA) submission instead of an EUA application” and “requested additional information and data”. Ocugen anticipates that data from additional clinical trials will be needed to support the submission. “We were close to finalising our EUA application when we received (FDA’s) recommendation to pursue a BLA path. While this will extend our timelines, we are committed to bringing Covaxin to the US,” said Ocugen’s Shankar Musunuri. agencies

Follow and connect with us on , Facebook, Linkedin

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.